1. Malaria prevention recommendations for risk groups visiting sub-Saharan Africa: A survey of European expert opinion and international recommendations 
Mithula Shellvarajah, Christoph Hatz, Patricia Schlagenhauf 
Travel Medicine and Infectious Disease 
DOI: /j.tmaid
Copyright © 2017 Elsevier Ltd Terms and Conditions

2. Fig. 1
Recommendation for a pregnant VFR (1st trimester) visiting her family in rural Nigeria.
P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None.
Travel Medicine and Infectious Disease DOI: ( /j.tmaid )
Copyright © 2017 Elsevier Ltd Terms and Conditions

3. Fig. 2
Recommendation for a baby (8 kg) visiting malaria-endemic areas of Sub-Saharan Africa for two weeks.
P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None.
Travel Medicine and Infectious Disease DOI: ( /j.tmaid )
Copyright © 2017 Elsevier Ltd Terms and Conditions

4. Fig. 3
Recommendation for a VFR family with limited budget returning to their country of origin in West Africa for a 2-month trip.
P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None.
Travel Medicine and Infectious Disease DOI: ( /j.tmaid )
Copyright © 2017 Elsevier Ltd Terms and Conditions

5. Fig. 4
Recommendation for an adult traveller with liver cirrhosis due to HCV visiting malaria-endemic areas of Sub-Saharan Africa.
P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None.
Travel Medicine and Infectious Disease DOI: ( /j.tmaid )
Copyright © 2017 Elsevier Ltd Terms and Conditions

6. Fig. 5
Recommendation for an adult traveller with renal impairment (GFR < 30 ml/min) visiting malaria-endemic areas of Sub-Saharan Africa.
P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None.
Travel Medicine and Infectious Disease DOI: ( /j.tmaid )
Copyright © 2017 Elsevier Ltd Terms and Conditions